Industry Research Reports
Global Obsessive-Compulsive Disorder Medicine Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-18
Pages: 117 Pages
Report ld: 2778419
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
The global Obsessive-Compulsive Disorder Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Obsessive-Compulsive Disorder Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Obsessive-Compulsive Disorder Medicine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Obsessive-Compulsive Disorder Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Obsessive-Compulsive Disorder Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Obsessive-Compulsive Disorder Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Obsessive-Compulsive Disorder Medicine sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Sun pharmaceuticals industry Ltd.
- H.Lunderbeck A/S
- Eli Lilly and company
- Apotex Inc.
- Viatris Inc.
- Lannett
- GlaxoSmithKline Plc.
- Alvogen
- Pfizer Inc.
- Amneal Pharmaceuticals LLC.
- Dr. Reddy's Laboratories Ltd.
- Abbott
- Par Pharmaceuticals
- Sebela Pharmaceuticals
- Mallinckrodt
- Lupin
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- NMDA Receptor Blockers
- Antipsychotics
- Antidepressants
Segment by Application
- Hospitals
- Homecare
- Clinics
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Obsessive-Compulsive Disorder Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Obsessive-Compulsive Disorder Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Obsessive-Compulsive Disorder Medicine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Obsessive-Compulsive Disorder Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Obsessive-Compulsive Disorder Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 NMDA Receptor Blockers
1.2.3 Antipsychotics
1.2.4 Antidepressants
1.3 Market by Application
1.3.1 Global Obsessive-Compulsive Disorder Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Obsessive-Compulsive Disorder Medicine Sales Estimates and Forecasts 2019-2030
2.2 Global Obsessive-Compulsive Disorder Medicine Revenue by Region
2.2.1 Global Obsessive-Compulsive Disorder Medicine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Obsessive-Compulsive Disorder Medicine Revenue by Region (2019-2024)
2.2.3 Global Obsessive-Compulsive Disorder Medicine Revenue by Region (2025-2030)
2.2.4 Global Obsessive-Compulsive Disorder Medicine Revenue Market Share by Region (2019-2030)
2.3 Global Obsessive-Compulsive Disorder Medicine Sales Estimates and Forecasts 2019-2030
2.4 Global Obsessive-Compulsive Disorder Medicine Sales by Region
2.4.1 Global Obsessive-Compulsive Disorder Medicine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Obsessive-Compulsive Disorder Medicine Sales by Region (2019-2024)
2.4.3 Global Obsessive-Compulsive Disorder Medicine Sales by Region (2025-2030)
2.4.4 Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Obsessive-Compulsive Disorder Medicine Sales by Manufacturers
3.1.1 Global Obsessive-Compulsive Disorder Medicine Sales by Manufacturers (2019-2024)
3.1.2 Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Obsessive-Compulsive Disorder Medicine in 2023
3.2 Global Obsessive-Compulsive Disorder Medicine Revenue by Manufacturers
3.2.1 Global Obsessive-Compulsive Disorder Medicine Revenue by Manufacturers (2019-2024)
3.2.2 Global Obsessive-Compulsive Disorder Medicine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Obsessive-Compulsive Disorder Medicine Revenue in 2023
3.3 Global Key Players of Obsessive-Compulsive Disorder Medicine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Obsessive-Compulsive Disorder Medicine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Obsessive-Compulsive Disorder Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Obsessive-Compulsive Disorder Medicine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Obsessive-Compulsive Disorder Medicine, Product Offered and Application
3.8 Global Key Manufacturers of Obsessive-Compulsive Disorder Medicine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Obsessive-Compulsive Disorder Medicine Sales by Type
4.1.1 Global Obsessive-Compulsive Disorder Medicine Historical Sales by Type (2019-2024)
4.1.2 Global Obsessive-Compulsive Disorder Medicine Forecasted Sales by Type (2025-2030)
4.1.3 Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Type (2019-2030)
4.2 Global Obsessive-Compulsive Disorder Medicine Revenue by Type
4.2.1 Global Obsessive-Compulsive Disorder Medicine Historical Revenue by Type (2019-2024)
4.2.2 Global Obsessive-Compulsive Disorder Medicine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Obsessive-Compulsive Disorder Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Obsessive-Compulsive Disorder Medicine Price by Type
4.3.1 Global Obsessive-Compulsive Disorder Medicine Price by Type (2019-2024)
4.3.2 Global Obsessive-Compulsive Disorder Medicine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Obsessive-Compulsive Disorder Medicine Sales by Application
5.1.1 Global Obsessive-Compulsive Disorder Medicine Historical Sales by Application (2019-2024)
5.1.2 Global Obsessive-Compulsive Disorder Medicine Forecasted Sales by Application (2025-2030)
5.1.3 Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Application (2019-2030)
5.2 Global Obsessive-Compulsive Disorder Medicine Revenue by Application
5.2.1 Global Obsessive-Compulsive Disorder Medicine Historical Revenue by Application (2019-2024)
5.2.2 Global Obsessive-Compulsive Disorder Medicine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Obsessive-Compulsive Disorder Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Obsessive-Compulsive Disorder Medicine Price by Application
5.3.1 Global Obsessive-Compulsive Disorder Medicine Price by Application (2019-2024)
5.3.2 Global Obsessive-Compulsive Disorder Medicine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Obsessive-Compulsive Disorder Medicine Market Size by Type
6.1.1 US & Canada Obsessive-Compulsive Disorder Medicine Sales by Type (2019-2030)
6.1.2 US & Canada Obsessive-Compulsive Disorder Medicine Revenue by Type (2019-2030)
6.2 US & Canada Obsessive-Compulsive Disorder Medicine Market Size by Application
6.2.1 US & Canada Obsessive-Compulsive Disorder Medicine Sales by Application (2019-2030)
6.2.2 US & Canada Obsessive-Compulsive Disorder Medicine Revenue by Application (2019-2030)
6.3 US & Canada Obsessive-Compulsive Disorder Medicine Market Size by Country
6.3.1 US & Canada Obsessive-Compulsive Disorder Medicine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Obsessive-Compulsive Disorder Medicine Sales by Country (2019-2030)
6.3.3 US & Canada Obsessive-Compulsive Disorder Medicine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Obsessive-Compulsive Disorder Medicine Market Size by Type
7.1.1 Europe Obsessive-Compulsive Disorder Medicine Sales by Type (2019-2030)
7.1.2 Europe Obsessive-Compulsive Disorder Medicine Revenue by Type (2019-2030)
7.2 Europe Obsessive-Compulsive Disorder Medicine Market Size by Application
7.2.1 Europe Obsessive-Compulsive Disorder Medicine Sales by Application (2019-2030)
7.2.2 Europe Obsessive-Compulsive Disorder Medicine Revenue by Application (2019-2030)
7.3 Europe Obsessive-Compulsive Disorder Medicine Market Size by Country
7.3.1 Europe Obsessive-Compulsive Disorder Medicine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Obsessive-Compulsive Disorder Medicine Sales by Country (2019-2030)
7.3.3 Europe Obsessive-Compulsive Disorder Medicine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Obsessive-Compulsive Disorder Medicine Market Size
8.1.1 China Obsessive-Compulsive Disorder Medicine Sales (2019-2030)
8.1.2 China Obsessive-Compulsive Disorder Medicine Revenue (2019-2030)
8.2 China Obsessive-Compulsive Disorder Medicine Market Size by Application
8.2.1 China Obsessive-Compulsive Disorder Medicine Sales by Application (2019-2030)
8.2.2 China Obsessive-Compulsive Disorder Medicine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Obsessive-Compulsive Disorder Medicine Market Size by Type
9.1.1 Asia Obsessive-Compulsive Disorder Medicine Sales by Type (2019-2030)
9.1.2 Asia Obsessive-Compulsive Disorder Medicine Revenue by Type (2019-2030)
9.2 Asia Obsessive-Compulsive Disorder Medicine Market Size by Application
9.2.1 Asia Obsessive-Compulsive Disorder Medicine Sales by Application (2019-2030)
9.2.2 Asia Obsessive-Compulsive Disorder Medicine Revenue by Application (2019-2030)
9.3 Asia Obsessive-Compulsive Disorder Medicine Sales by Region
9.3.1 Asia Obsessive-Compulsive Disorder Medicine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Obsessive-Compulsive Disorder Medicine Revenue by Region (2019-2030)
9.3.3 Asia Obsessive-Compulsive Disorder Medicine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Market Size by Type
10.1.1 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Market Size by Application
10.2.1 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Sales by Country
10.3.1 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Obsessive-Compulsive Disorder Medicine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sun pharmaceuticals industry Ltd.
11.1.1 Sun pharmaceuticals industry Ltd. Company Information
11.1.2 Sun pharmaceuticals industry Ltd. Overview
11.1.3 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sun pharmaceuticals industry Ltd. Recent Developments
11.2 H.Lunderbeck A/S
11.2.1 H.Lunderbeck A/S Company Information
11.2.2 H.Lunderbeck A/S Overview
11.2.3 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 H.Lunderbeck A/S Recent Developments
11.3 Eli Lilly and company
11.3.1 Eli Lilly and company Company Information
11.3.2 Eli Lilly and company Overview
11.3.3 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly and company Recent Developments
11.4 Apotex Inc.
11.4.1 Apotex Inc. Company Information
11.4.2 Apotex Inc. Overview
11.4.3 Apotex Inc. Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Apotex Inc. Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Inc. Recent Developments
11.5 Viatris Inc.
11.5.1 Viatris Inc. Company Information
11.5.2 Viatris Inc. Overview
11.5.3 Viatris Inc. Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Viatris Inc. Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Viatris Inc. Recent Developments
11.6 Lannett
11.6.1 Lannett Company Information
11.6.2 Lannett Overview
11.6.3 Lannett Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Lannett Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lannett Recent Developments
11.7 GlaxoSmithKline Plc.
11.7.1 GlaxoSmithKline Plc. Company Information
11.7.2 GlaxoSmithKline Plc. Overview
11.7.3 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline Plc. Recent Developments
11.8 Alvogen
11.8.1 Alvogen Company Information
11.8.2 Alvogen Overview
11.8.3 Alvogen Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Alvogen Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Alvogen Recent Developments
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Information
11.9.2 Pfizer Inc. Overview
11.9.3 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pfizer Inc. Recent Developments
11.10 Amneal Pharmaceuticals LLC.
11.10.1 Amneal Pharmaceuticals LLC. Company Information
11.10.2 Amneal Pharmaceuticals LLC. Overview
11.10.3 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amneal Pharmaceuticals LLC. Recent Developments
11.11 Dr. Reddy's Laboratories Ltd.
11.11.1 Dr. Reddy's Laboratories Ltd. Company Information
11.11.2 Dr. Reddy's Laboratories Ltd. Overview
11.11.3 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dr. Reddy's Laboratories Ltd. Recent Developments
11.12 Abbott
11.12.1 Abbott Company Information
11.12.2 Abbott Overview
11.12.3 Abbott Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Abbott Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Abbott Recent Developments
11.13 Par Pharmaceuticals
11.13.1 Par Pharmaceuticals Company Information
11.13.2 Par Pharmaceuticals Overview
11.13.3 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Par Pharmaceuticals Recent Developments
11.14 Sebela Pharmaceuticals
11.14.1 Sebela Pharmaceuticals Company Information
11.14.2 Sebela Pharmaceuticals Overview
11.14.3 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sebela Pharmaceuticals Recent Developments
11.15 Mallinckrodt
11.15.1 Mallinckrodt Company Information
11.15.2 Mallinckrodt Overview
11.15.3 Mallinckrodt Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Mallinckrodt Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Mallinckrodt Recent Developments
11.16 Lupin
11.16.1 Lupin Company Information
11.16.2 Lupin Overview
11.16.3 Lupin Obsessive-Compulsive Disorder Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Lupin Obsessive-Compulsive Disorder Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Lupin Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Obsessive-Compulsive Disorder Medicine Industry Chain Analysis
12.2 Obsessive-Compulsive Disorder Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Obsessive-Compulsive Disorder Medicine Production Mode & Process
12.4 Obsessive-Compulsive Disorder Medicine Sales and Marketing
12.4.1 Obsessive-Compulsive Disorder Medicine Sales Channels
12.4.2 Obsessive-Compulsive Disorder Medicine Distributors
12.5 Obsessive-Compulsive Disorder Medicine Customers
13 Market Dynamics
13.1 Obsessive-Compulsive Disorder Medicine Industry Trends
13.2 Obsessive-Compulsive Disorder Medicine Market Drivers
13.3 Obsessive-Compulsive Disorder Medicine Market Challenges
13.4 Obsessive-Compulsive Disorder Medicine Market Restraints
14 Key Findings in The Global Obsessive-Compulsive Disorder Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Global Obsessive-Compulsive Disorder Medicine Market Research Report 2025
The global market for Obsessive-Compulsive Disorder Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 100
USD 2900.00
(Single User License)
Obsessive-Compulsive Disorder Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Published Date: 2024-02-23
Pages: 139
USD 3950.00
(Single User License)
Global Obsessive-Compulsive Disorder Medicine Market Research Report 2024
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Published Date: 2024-01-16
Pages: 101
USD 2900.00
(Single User License)
Global Obsessive-Compulsive Disorder Medicine Market Research Report 2025
The global market for Obsessive-Compulsive Disorder Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 100
USD 2900.00 (Single User License)Obsessive-Compulsive Disorder Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Published: 2024-02-23
Pages: 139
USD 3950.00 (Single User License)Global Obsessive-Compulsive Disorder Medicine Market Research Report 2024
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Published: 2024-01-16
Pages: 101
USD 2900.00 (Single User License)
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now